News
Medical device company ArthroCare announced Monday that it has reached an agreement in principle to settle an investors' class action lawsuit pending against the company and two of its former officers for $74 million.
The California Hospital Association last week petitioned a federal district court to grant a preliminary injunction against California's Medicaid program, called Medi-Cal, to prevent it from making 10 percent reimbursement cuts primarily affecting hospital-based skilled nursing facilities.
The Senior Medicare Patrol (SMP) has been given a $9 million grant from the Centers for Medicare & Medicaid Services (CMS) to continue combating Medicare fraud.
Officials at Accenture and AT&T have launched a new medical imaging solution they say will help hospitals access medical images and doctors to collaborate.
It’s no wonder why subscribers of Wolters Kluwer Health’s UpToDate have described the system as “the best medical tool ever.” New research conducted at Harvard University has found that hospitals using UpToDate, an evidence-based, physician-authored clinical knowledge system, have shorter lengths of stay, better quality and, for some conditions, a lower mortality rate.
After a political impasse, in which Republicans effectively blocked his Senate confirmation, Donald Berwick, MD, will step down next week as administrator of the Centers for Medicare & Medicaid Services. President Obama has nominated CMS principal deputy Marilynn Tavenner as Berwick's replacement.
As workers continue to pick up more of the costs associated with employer-sponsored health plans, they want more help from their employers to manage their health and get the most out of their health plans, according to a new survey from Aon Hewitt.
Medicare Advantage members in Pennsylvania who enrolled in a Health Quality Partners (HQP) care management program had 20 percent fewer inpatient hospital admissions, according to a report issued by Aetna on Nov. 16.
One of the country's largest drugmakers, Merck, will pay nearly $1 billion to settle criminal and civil charges related to its marketing of the painkiller Vioxx the Justice Department announced Tuesday.
The three pillars of what's often dubbed Newt Inc. -- two for-profit groups and one defunct political committee -- raked in more than $105 million in revenue and donations from 2001 through 2010 while Newt Gingrich was eyeing a political comeback.